Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Colossal Biosciences is reportedly in talks to raise fresh capital at a $20 billion to $30 billion valuation, up from $10.2 billion about 16 months ago. The company has begun gener...





